The NYU Division of Nephrology is part of a multi-institutional glomerulornephritis consortium that will address the impact of various therapeutic interventions in randomized trials in seven different glomerular diseases. R33 grant applications will be submitted to NIDDK/NIH between March and December 2004 for new therapeutic trials including: